A team of researchers has identified a chemical that could potentially be used in eye drops to reverse cataracts the leading cause of blindness. UC San Francisco (UCSF) the University of Michigan (U-M) and Washington University in St. Louis (WUSTL) researchers' newly identified compound is the first that is soluble enough to potentially form the basis of a practical eye-drop medication for cataracts. Cataracts are primarily a disease of aging. As is seen in neurodegenerative conditions such as Alzheimer's disease and Parkinson's disease a hallmark of the condition is the misfolding and clumping together of crucial proteins. In the case
